ACI’s 28th Annual Drug & Medical Device Litigation Conference
Event | 12.05.23, 2:00 PM EST
Address
NY Marriott Marquis
1535 Broadway, New York, NY 10036
On December 5, Andrew Kaplan will speak at ACI’s 28th Annual Drug & Medical Device Litigation Conference on the panel, "Key Takeaways from this Year’s Top MDLs: Impactful Rulings and Hot Opinions from the Tylenol, Zantac and Exactech MDLs.” This program will analyze the nuances of these three MDLs and provide insights on how developments in recent OTC MDLs may impact the future of prescription pharmaceuticals.
For more information, please visit these areas: Mass Tort, Product, and Consumer Litigation
Participants
Insights
Event | 05.14.25
"The Tide is High New Guidance on Sea-Level Rise," The Environmental Law Section
On December 5, 2024, the San Francisco Bay Conservation and Development Commission (BCDC) adopted the Regional Shoreline Adaptation Plan (RSAP). The RSAP is a region-wide plan for the San Francisco Bay shoreline that guides the creation of coordinated, locally planned sea level rise adaptation actions that work together to achieve a regional One Bay Vision. This includes BCDC’s guidelines for how local governments must meet the requirements of SB 272, a new State mandate that requires all local governments along the shoreline to prepare a Subregional Shoreline Adaptation Plan by 2034. Jon Welner will be the moderator and will be interviewing the Executive Director of the SF Bay Conservation and Development Commission (SF BCDC), which regulates all development in or near San Francisco Bay.
Event | 05.13.25 - 05.14.25
Government Contractors Reacting and Adapting to the New Administration (OOPS 2025)
Event | 02.25.25
